Literature DB >> 16639274

Meniere's disease: prevalence of contralateral ear involvement.

John W House1, Joni K Doherty, Laurel M Fisher, M Jennifer Derebery, Karen I Berliner.   

Abstract

OBJECTIVE: Determine the prevalence and time interval for conversion from unilateral to bilateral involvement in Meniere's disease and cochlear hydrops. STUDY DESIGN AND
SETTING: Retrospective chart review in a tertiary otologic referral center. PATIENTS: 232 patients diagnosed with Meniere's Disease (n=186) or cochlear hydrops (n=46) between 1959 and 2001, who visited the clinic over a five-year period between 1997-2001 and have at least 2 audiograms more than 12 months apart. MAIN OUTCOME MEASURES: Prevalence of cochlear hydrops relative to Meniere's Disease, rate of progression from unilateral to bilateral involvement; interval between unilateral onset of symptoms and bilateral involvement; and rate of progression from cochlear hydrops to Meniere's disease.
RESULTS: Initial diagnosis was Meniere's disease in 71% and cochlear hydrops in 29% of all 950 hydropic patients presenting between 1997 and 2001. In the study sample, Meniere's disease was bilateral at presentation in 11%; an additional 12% (14% of unilaterals) became bilateral during the follow-up period. At presentation, 6.5% of cochlear hydrops patients were bilateral, with another 26% becoming bilateral. Conversion from cochlear hydrops to Meniere's disease occurred in 33% and some of these are included among the bilateral. The average time interval for conversion from unilateral to bilateral Meniere's was 7.6 years (SD=7.0 years).
CONCLUSION: Most otologists are aware of the potential for contralateral ear involvement and conversion from cochlear hydrops to Meniere's disease after diagnosis. These changes are significant, require long-term follow-up for detection, and may necessitate further treatment. Patients should be counseled regarding this potential when interventions are considered, especially with respect to ablative treatments.

Entities:  

Mesh:

Year:  2006        PMID: 16639274     DOI: 10.1097/00129492-200604000-00011

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  19 in total

1.  [Low frequency fluctuating hearing loss without labyrinthine vertigo--a genuine disease? A follow up study after 4 and 10 years].

Authors:  H Schaaf; G Hesse
Journal:  HNO       Date:  2007-08       Impact factor: 1.284

2.  Meniere's disease: rare or underdiagnosed among Africans.

Authors:  T S Ibekwe; G T A Ijaduola
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-07-04       Impact factor: 2.503

Review 3.  [Surgical therapy in Menière's disease. Historical development and today's state of the art].

Authors:  G Baier; I Ott
Journal:  HNO       Date:  2008-05       Impact factor: 1.284

4.  Meniere's disease: Still a mystery disease with difficult differential diagnosis.

Authors:  A Vassiliou; P V Vlastarakos; P Maragoudakis; D Candiloros; T P Nikolopoulos
Journal:  Ann Indian Acad Neurol       Date:  2011-01       Impact factor: 1.383

5.  Therapeutic strategies in the treatment of Menière's disease: the Italian experience.

Authors:  Nicola Quaranta; P Picciotti; G Porro; B Sterlicchio; G Danesi; P Petrone; Giacinto Asprella Libonati
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-04-11       Impact factor: 2.503

6.  Cervical Vestibular Evoked Myogenic Potentials in Menière's Disease: A Comparison of Response Metrics.

Authors:  Kimberley S Noij; Barbara S Herrmann; John J Guinan; Steven D Rauch
Journal:  Otol Neurotol       Date:  2019-03       Impact factor: 2.311

7.  A novel missense variant in PRKCB segregates low-frequency hearing loss in an autosomal dominant family with Meniere's disease.

Authors:  Carmen Martín-Sierra; Teresa Requena; Lidia Frejo; Steven D Price; Alvaro Gallego-Martinez; Angel Batuecas-Caletrio; Sofía Santos-Pérez; Andrés Soto-Varela; Anna Lysakowski; Jose A Lopez-Escamez
Journal:  Hum Mol Genet       Date:  2016-06-21       Impact factor: 6.150

8.  Variable expressivity and genetic heterogeneity involving DPT and SEMA3D genes in autosomal dominant familial Meniere's disease.

Authors:  Carmen Martín-Sierra; Alvaro Gallego-Martinez; Teresa Requena; Lidia Frejo; Angel Batuecas-Caletrío; Jose A Lopez-Escamez
Journal:  Eur J Hum Genet       Date:  2016-11-23       Impact factor: 4.246

Review 9.  Allergy and Ménière's disease.

Authors:  M Jennifer Derebery; Karen I Berliner
Journal:  Curr Allergy Asthma Rep       Date:  2007-11       Impact factor: 4.806

10.  Chemical labyrinthectomy for the worse ear of adult Nigerians with bilateral Meniere's disease: preliminary report of treatment outcomes.

Authors:  A D Olusesi; S B Hassan; Y Oyeyipo; U C Ukwuije; O Oyeniran
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-02-26       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.